TY  - GEN
AU  - Hoskins,Paul J
AU  - Fung-Kee-Fung,Michael
AU  - Miller,Dianne
AU  - Gotlieb,Walter
TI  - Time for a level playing field: inequalities in regulatory/approval processes—the example of bevacizumab in epithelial ovarian cancer
SN  - 1527-7755
PY  - 2015///0720
KW  - Antibodies, Monoclonal, Humanized
KW  - economics
KW  - Antineoplastic Agents
KW  - Bevacizumab
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Canada
KW  - Carcinoma, Ovarian Epithelial
KW  - Clinical Trials as Topic
KW  - Colorectal Neoplasms
KW  - Cost-Benefit Analysis
KW  - Disease-Free Survival
KW  - Drug Approval
KW  - Drug Costs
KW  - European Union
KW  - Evidence-Based Medicine
KW  - Female
KW  - Humans
KW  - Lung Neoplasms
KW  - Neoplasms, Glandular and Epithelial
KW  - Ovarian Neoplasms
KW  - Politics
KW  - Recurrence
KW  - Survival Analysis
KW  - Treatment Outcome
KW  - United Kingdom
KW  - United States
KW  - United States Food and Drug Administration
KW  - Vascular Endothelial Growth Factor A
KW  - antagonists & inhibitors
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1200/JCO.2014.58.3690
ER  -